Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 13, 2026

GALT — Galectin Therapeutics Inc. Dilution Risk Tracker

Track GALT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GALT — Get alerts when the score changes →

As of October 13, 2026, Galectin Therapeutics Inc. (GALT) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Galectin Therapeutics Inc. has a market capitalization of $390.29M, 100.85M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 4.17M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
85
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔄 Reverse Split model est. 15%
• Only 5 months cash — financial pressure
🔔 Track GALT — Get forecast alerts →

Market Data

Market Cap$390.29M
Shares Outstanding100.85M
Float47.19M
Cash$13.27M
Debt$138.70M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding100.85MVerified float table or market cache
Public Float47.19MVerified float table or market cache
Market Cap$390.29MMarket data cache
Cash Runway4.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants4.17MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: FORM 4 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

1 institutional holders · 12.4K shares
#1 49 WEALTH MANAGEMENT, LLC 12.4K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.21M
Days to Cover33.7
% of Float19.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2022-03-31
Form 4 INSIDER TRANSACTION 2026-07-31
Form 4 INSIDER TRANSACTION 2026-07-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GALT Dilution Snapshot

Galectin Therapeutics Inc. (GALT) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GALT's DilutionScore is currently 52/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 51/100 (High risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202652/100HIGH14 days
Aug 22 – Sep 29, 202651/100HIGH39 days
Aug 14 – Aug 21, 202655/100HIGH7 days
Jul 16 – Aug 13, 202650/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

GALT shares outstanding have increased 2.1% from 64.47M (Mar 2026) to 65.86M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202665.86M47.19M▲ 0.02%
May 17, 202665.83M47.18M▲ 0.04%
Apr 07, 202665.83M47.16M▲ 0.84%
Apr 03, 202665.83M46.77M▲ 2.10%
Mar 05, 202664.47M45.80M▲ 0.12%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track GALT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GALT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GALT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GALT
GALT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.